Tech Company Financing Transactions
TrialJectory Funding Round
TrialJectory, based in New York, raised $20 million in investment from Insight Venture Partners, Contour Venture Partners and JAL Ventures.
Transaction Overview
Company Name
Announced On
2/14/2022
Transaction Type
Venture Equity
Amount
$20,000,000
Round
Series A
Investors
Insight Venture Partners (Lead Investor) (Scott Barclay)
Proceeds Purpose
Trialjectory will use the funding to transform cancer care by defining a new market category focused on delivering personalized, treatment decision-support and a new way for pharma to offer an authentic, patient-centered experience.
Company Information
Company Status
Private & Independent
Industry
Healthcare IT
Mailing Address
119W 24 St.
New York, NY 10019
USA
New York, NY 10019
USA
Phone
Undisclosed
Website
Email Address
Overview
Trialjectory.com is an AI-based trial matching platform that uses self-reported clinical information to facilitate clinical trial search, matching and enrollment by cancer patients and their physicians.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Tzvia Bader
Co-Founder
Avital Gaziel
VP - Product Management
Noam Geva
Browse more venture capital transactions:
Prev: 2/14/2022: Alchemy venture capital transaction
Next: 2/14/2022: Watershed venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to record funding rounds that are announced publicly. All VC database entries reported here come from publicly available VC deal announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs